Global Allergy Diagnostic Service Market Growth (Status and Outlook) 2025-2031

The global Allergy Diagnostic Service market size is predicted to grow from US$ 5619 million in 2025 to US$ 6976 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.

Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Allergy Diagnostic Service Industry Forecast” looks at past sales and reviews total world Allergy Diagnostic Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Allergy Diagnostic Service sales for 2025 through 2031. With Allergy Diagnostic Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Diagnostic Service industry.

This Insight Report provides a comprehensive analysis of the global Allergy Diagnostic Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Allergy Diagnostic Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allergy Diagnostic Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Diagnostic Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Diagnostic Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Diagnostic Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Blood Tests
Skin-prick Tests
Food Challenge Tests
Others

Segmentation by Application:
Drug Developer
Hospital
Medical Research Institute
Patients

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc
Siemens Healthcare GmbH
Allergy Diagnostics
EUROIMMUN Medizinische Labordiagnostika AG
Labcorp
Wycoff Wellness
GMC Medical Center
Bausch & Lomb Incorporated
Personal Physician Care
DST Diagnostische Systeme & Technologien GmbH
Foothills ENT
Quest Diagnostics Incorporated
Latitude
P.H.Diagnostic Centre
CADUCEUS MEDICAL GROUP
Vanguard Medical Group, P.A.
Dia Lab Services Srl

Please note: The report will take approximately 2 business days to prepare and deliver.